Mathematical modelling of molecular pathways enabling tumour cell invasion and migration DPA Cohen, L Martignetti, S Robine, E Barillot, A Zinovyev, L Calzone PLoS computational biology 11 (11), e1004571, 2015 | 147 | 2015 |
Aberrant ERBB4-SRC signaling as a hallmark of group 4 medulloblastoma revealed by integrative phosphoproteomic profiling A Forget, L Martignetti, S Puget, L Calzone, S Brabetz, D Picard, ... Cancer cell 34 (3), 379-395. e7, 2018 | 145 | 2018 |
Concomitant Notch activation and p53 deletion trigger epithelial-to-mesenchymal transition and metastasis in mouse gut M Chanrion, I Kuperstein, C Barrière, F El Marjou, D Cohen, D Vignjevic, ... Nature communications 5 (1), 5005, 2014 | 139 | 2014 |
Gene signature extraction and cell identity recognition at the single-cell level with Cell-ID A Cortal, L Martignetti, E Six, A Rausell Nature biotechnology 39 (9), 1095-1102, 2021 | 103 | 2021 |
Identification of microRNA clusters cooperatively acting on epithelial to mesenchymal transition in triple negative breast cancer L Cantini, G Bertoli, C Cava, T Dubois, A Zinovyev, M Caselle, ... Nucleic acids research 47 (5), 2205-2215, 2019 | 78 | 2019 |
Classification of gene signatures for their information value and functional redundancy L Cantini, L Calzone, L Martignetti, M Rydenfelt, N Blüthgen, E Barillot, ... NPJ systems biology and applications 4 (1), 2, 2017 | 70 | 2017 |
ROMA: representation and quantification of module activity from target expression data L Martignetti, L Calzone, E Bonnet, E Barillot, A Zinovyev Frontiers in genetics 7, 18, 2016 | 53 | 2016 |
Quantitative proteome landscape of the NCI-60 cancer cell lines T Guo, A Luna, VN Rajapakse, CC Koh, Z Wu, W Liu, Y Sun, H Gao, ... Iscience 21, 664-680, 2019 | 51 | 2019 |
Conceptual and computational framework for logical modelling of biological networks deregulated in diseases A Montagud, P Traynard, L Martignetti, E Bonnet, E Barillot, A Zinovyev, ... Briefings in bioinformatics 20 (4), 1238-1249, 2019 | 20 | 2019 |
Convergent network effects along the axis of gene expression during prostate cancer progression K Charmpi, T Guo, Q Zhong, U Wagner, R Sun, NC Toussaint, CE Fritz, ... Genome Biology 21, 1-31, 2020 | 18 | 2020 |
A review of computational approaches detecting microRNAs involved in cancer L Cantini, M Caselle, A Forget, A Zinovyev, E Barillot, L Martignetti Frontiers in Bioscience 22, 1774-1791, 2017 | 18 | 2017 |
Investigating the epi-miRNome: Identification of epi-miRNAs using transfection experiments E Reale, D Taverna, L Cantini, L Martignetti, M Osella, C De Pittà, F Virga, ... Epigenomics 11 (14), 1581-1599, 2019 | 16 | 2019 |
Detection of miRNA regulatory effect on triple negative breast cancer transcriptome L Martignetti, B Tesson, A Almeida, A Zinovyev, GC Tucker, T Dubois, ... BMC genomics 16, 1-10, 2015 | 15 | 2015 |
Severe hematopoietic stem cell inflammation compromises chronic granulomatous disease gene therapy S Sobrino, A Magnani, M Semeraro, L Martignetti, A Cortal, A Denis, ... Cell Reports Medicine 4 (2), 2023 | 11 | 2023 |
Antagonism pattern detection between MicroRNA and target expression in ewing’s sarcoma L Martignetti, K Laud-Duval, F Tirode, G Pierron, S Reynaud, E Barillot, ... PLoS One 7 (7), e41770, 2012 | 9 | 2012 |
Urinary exosomes of patients with cystic fibrosis unravel CFTR-related renal disease S Gauthier, I Pranke, V Jung, L Martignetti, V Stoven, T Nguyen-Khoa, ... International Journal of Molecular Sciences 21 (18), 6625, 2020 | 8 | 2020 |
Universal power law behaviors in genomic sequences and evolutionary models L Martignetti, M Caselle Physical Review E—Statistical, Nonlinear, and Soft Matter Physics 76 (2 …, 2007 | 7 | 2007 |
Quantitative Proteome Landscape of the NCI-60 Cancer Cell Lines. iScience 2019, 21, 664–680 T Guo, A Luna, VN Rajapakse, CC Koh, Z Wu, W Liu, Y Sun, H Gao, ... DOI, 0 | 7 | |
Rapid proteotyping reveals cancer biology and drug response determinants in the NCI-60 cells T Guo, A Luna, VN Rajapakse, CC Koh, Z Wu, MP Menden, Y Cheng, ... BioRxiv, 268953, 2018 | 6 | 2018 |
Results from a Phase I/II Clinical Trial for X Linked Chronic Granulomatous Disease (CGD): Possible Impact of Inflammation on Gene Therapy Efficacy A Magnani, C Cousin Mol. Ther 28, 2020 | 3 | 2020 |